Conference on Neurodegenerative Diseases and Treatments
Official title: CSHL 2024 Conference on Neurodegenerative Diseases: Biology & Therapeutics
Funded at Cold Spring Harbor Laboratory · NIH-10994945 · Data updated 2026-11-12
This conference is bringing together scientists and researchers to share ideas and discoveries about diseases like Alzheimer's and ALS, with the goal of finding better ways to understand and treat these conditions.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cold Spring Harbor Laboratory NIH-funded |
| Lab location | 1 site (Cold Spring Harbor, United States) |
| Project start | July 15, 2024 |
| Project end | June 30, 2025 |
| Funding year | 2024 |
| Award (this year) | $32,925 |
| NIH project number | 1R13AG089879-01 |
| Project ID | NIH-10994945 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients with neurodegenerative diseases like Alzheimer's or ALS may benefit from the advancements discussed at this conference.
✕Less likely to help
Patients with non-neurodegenerative conditions will likely not receive direct benefits from this conference.
What this research studies
This conference will gather scientists and researchers to discuss the biology and treatment of neurodegenerative diseases such as Alzheimer's and ALS. Attendees will share their findings on disease mechanisms, potential biomarkers, and therapeutic strategies aimed at halting disease progression. The event will foster collaboration between academic and industry experts to advance understanding and treatment options for these conditions. It will include sessions on various aspects of neurodegeneration, including glial biology and immune responses.
Why it matters
Potential benefit: If successful, this conference could lead to new insights and collaborations that improve treatment options for patients with neurodegenerative diseases.
How similar studies have gone: Previous conferences on similar topics have successfully led to advancements in understanding and treating neurodegenerative diseases.
Where this research is happening
-
Cold Spring Harbor Laboratory
Cold Spring Harbor, United States Active
Researchers
- Principal investigator: Stewart, David J. — Cold Spring Harbor Laboratory
- Study coordinator: Stewart, David J.
Related research
Other NIH-funded projects on the same topics.
-
Developing small molecules to treat TDP-43 related brain diseases
A potential new drug candidate (XL20) for diseases like Alzheimer’s and other dementias linked to TDP-43 protein problems is being developed and refined for people who live with these conditions.
-
Tau filament structure in Alzheimer’s and related dementias
Aims to map the detailed 3D shapes of tau protein filaments found in human brain diseases to help develop better diagnostics and treatments for Alzheimer’s-related dementias.
-
Targeting RNA Splicing Abnormalities in ALS/FTD
A research team aims to understand and correct abnormal RNA splicing in ALS and related brain diseases to help patients in the future.
-
Blood-brain barrier–friendly imaging agents for neurodegenerative diseases
A researcher team will test new imaging agents that can cross the brain barrier to help detect Alzheimer’s and related diseases earlier and more accurately.
-
Brain cell–derived EV markers to differentiate Alzheimer’s and related dementias
A Mayo Clinic team is testing brain-cell–specific tiny particles in blood to tell apart Alzheimer’s disease and similar dementias using advanced machine-learning analysis.
-
Fisetin approach to reduce vulnerability to community infections in aging veterans
A patient-friendly look at a study testing whether the natural compound fisetin can help aging Veterans stay healthier when they face common infections.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.